Latest Going Concern News

Robex Resources Inc reported a substantial net loss for the first half of 2025, reflecting operational challenges and legal settlements, while advancing financing and construction of its key Kiniéro gold project in Guinea.

Red Mountain Mining Ltd has announced a pro-rata non-renounceable entitlement issue of RMXO Options priced at $0.001 each, aiming to raise up to $193,499 to support its working capital needs. The offer, exercisable at $0.02 until May 2027, carries notable risks including dilution and going concern uncertainties.

Euro Manganese Inc. reported a $12.8 million loss for the nine months ended June 30, 2025, while securing $11.1 million in equity financing and amending its $20 million convertible loan facility. The company highlights ongoing funding risks as it advances its manganese projects.

Anatara Lifesciences reported a 35% rise in net loss to $1.95 million for FY25, following pivotal Phase II trial results for its GaRP product that missed the primary efficacy endpoint but showed promising secondary benefits. The company is advancing commercialisation efforts and launching a new anti-obesity project amid tightened cash reserves.

Oneview Healthcare PLC reported a 36% increase in revenue for the first half of 2025, driven by strong deployment activity and new US customers, while managing a wider net loss due to FX impacts and restructuring costs.

My Foodie Box Limited reported a significantly reduced net loss for the half year ended December 2024 following the divestment of its meal kit business. The company is actively pursuing new acquisitions and funding to restore shareholder value and regain its ASX listing.

Nutritional Growth Solutions Ltd has clarified discrepancies in its June 2025 quarterly reports, attributing changes to timing and classification adjustments, while reaffirming its financial health and governance compliance.

Resouro Strategic Metals reports a significant update to its Tiros project resource alongside a reduced quarterly loss, highlighting progress in its Brazilian exploration assets.

Anteris Technologies Global Corp. reported a $42.7 million net loss for the first half of 2025 amid advancing preparations for its pivotal DurAVR Transcatheter Heart Valve trial. The company’s recent IPO proceeds are fueling R&D and manufacturing scale-up as it targets regulatory approvals.

Coronado Global Resources reported a $172.4 million net loss for the half-year ended June 30, 2025, driven by falling metallurgical coal prices and reduced sales volumes. The company initiated liquidity measures including a $75 million coal prepayment and debt refinancing, but credit rating downgrades have cast doubt on its going concern status.

Metro Performance Glass proposes a $15–24 million recapitalisation involving a discounted rights offer and a major placement to Amari Metals, who would become the controlling shareholder.

AVITA Medical reported a 21% revenue increase in Q2 2025 driven by expanded sales and new product launches, yet continues to face net losses and liquidity challenges requiring loan covenant waivers.